Remove about
article thumbnail

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

Should the final rules limit the issuance of prescriptions of controlled medications to the FDA-approved indications contained in the FDA-approved labeling for those medications? Provider Education and Understanding About New Prescribing and Recordkeeping Requirements. Impact On Off-label Prescribing of Controlled Substances.

article thumbnail

Five Public Health Needs for Digital Health Technology

The Digital Health Corner

The Substance Abuse and Mental Health Services Administration recently released a free mobile app for clinicians called MATx. Nutrition is an important aspect of a child’s health regardless of age. It provides information and guidance to medication assisted treatment of opioid addiction. Childhood nutrition.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps 

Bill of Health

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone.

article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

Section 3602 of the Act requires FDA to issue new guidance or update existing guidance specifying the form and content of diversity action plans for enrollment, disaggregated by age, group, sex, and racial and ethnic demographic characteristics of clinically relevant populations.

Medicaid 104